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Intracellular Neutralization of HIV
Transcytosis across Tight Epithelial Barriers
by Anti-HIV Envelope Protein dIgA or IgM
The central role of S-IgA and S-IgM in protecting mu-
cosal surfaces relies on the existence of an active mech-
anism used to transport these polymeric immunoglobu-
lins (pIgs) from their site of synthesis to their effector
site in the secretion. S-IgA, which is mostly dimeric, or
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ICGM S-IgM, which is pentameric, are synthesized and se-
creted from plasma (B) cells in the submucosa as poly-75014 Paris
meric Igs, i.e., dimeric IgA (dIgA) or pentameric IgMFrance
(IgM). The stability of these pIgs depends on an addi-2CJF 98-X INSERM
tional polypeptide, the J chain, which isadded duringpIgFaculteÂ Necker-Enfants Malades
assembly and secretion. To gain access to the mucosal75730 Paris
lumen, dIgA or IgM (containing the J chain) bind to theFrance
polymeric immunoglobulin receptor (pIg-R) located at3U430 INSERM
the serosal (basolateral) surface of overlying epitheliumHopital Broussais
(reviewed in Mostov and Kaetzel, 1998). The dIgA or75014 Paris
IgM/pIg-R complex is internalized, delivered to an endo-France
somal compartment, and subsequently translocated to4Biologie des Retrovirus
the apical (mucosal) pole of the epithelial cell in a pro-Institut Pasteur
cess termed transcytosis. Transcytosis is a vesicular,75015 Paris
transcellular pathway characteristic of polarized epithe-France
lial cells. At the apical surface, the extracellular ligand-5Hopital Saint Vincent de Paul
binding portion of the pIg-R, known as the secretory74014 Paris
component (SC), is proteolytically cleaved. This cleav-France
age results in the release of the pIg-SC complexÐnow6U271 INSERM
termed secretory IgA or M; i.e., S-IgA or MÐinto secre-69424 Lyon
tions. The J chain is characteristic of pIgs and is requiredFrance
for their specific binding to the pIg-R and access to
the lumen via pIg-R-mediated transcytosis. In contrast,
monomeric immunoglobulins A or G lacking the J chainSummary
are unable to use such a pathway.
The role of S-IgA in viral neutralization has been dem-Human immunodeficiency virus, generated during
onstrated for many different viruses (for review, seecontact between HIV-infected cells and the apical sur-
Castello-Branco et al., 1996) including our study on theface of an epithelial cell, can cross a tight epithelial
human immunodeficiencyvirus (HIV) (Hocini et al., 1997).barrier by transcytosis. We show that transcytosis of
Mazanec et al. suggested from a set of elegant studiesprimary HIV isolates is blocked by dimeric IgA or IgM
that dIgA may also act to neutralize viral infection withinagainst HIV envelope proteins. Neutralization occurs
the epithelial cell (Mazanec et al., 1993). Furthermore,intracellularly within the apical recycling endosome,
in a mouse model, specific dIgA against rotavirus wasand immune complexes are specifically recycled to
protective against mucosal rotavirus infection. Neutral-the mucosal surface. One epitope involved in neutral-
ization most likely occurred within the epithelial cellsization is a conserved sequence of the gp41 HIV enve-
(Burns et al., 1996). While the above data are suggestivelope protein subunit. Finally, transcytosis also occurs
that intracellular neutralization can occur, the actual in-across functional human mucosal tissue in a process
tracellular site where dIgA and virus meet has not beeninhibited by a serosal internalization of IgM against
established.the HIV envelope protein. These results suggest that
Mucosal surfaces are the major site of natural HIVinduction of mucosal immunity to HIV envelope pro-
infection, even when the efficiency of infection is lowteins may impair the transcytotic route of HIV mucosal
compared to the frequency of direct HIV exposure (Nico-transmission.
losi et al., 1994). Mucosal immunity has been suggested
to account for at least some host resistance to infection.Introduction
Specific anti-HIV S-IgA has been detected at mucosal
sites of most uninfected partners of couples discordant
Secretory IgA (S-IgA), the major effector molecule of the
for HIV infection (Mazzoli et al., 1997). Protective muco-
mucosal immune system, and secretory IgM (S-IgM)
sal immunity is elicited in macaques by lymph node
form the first line of immunological defense at mucosal
immunization (Lehner et al., 1996). Protection against
surfaces against many microbial pathogens, including
challenge with SIV is correlated with an increased num-
viruses. Resistance to viral infection correlates with
ber of IgA-secreting plasma cells, and neutralization of
the specific S-IgA in mucosal secretions (reviewed in
HIV is achieved by S-IgA (fecal) induced by oral immuni-
Brandtzaeg, 1997).
zation (Bukawa et al., 1995).
Although the first steps of mucosal HIV transmission
are not well understood, it isbecoming increasingly clear7 To whom correspondence should be addressed (e-mail: bomsel@
lovelace.infobiogen.fr). that the type of epithelium of the mucosa is an important
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determinant in the mechanism of infection. In mucosa
comprised of a pluristratified epithelium (e.g., like that
of the vagina, exocervix, foreskin, and anus), dendritic
cells appear to be the first target of HIV, leading to its
dissemination in the submucosa without epithelial cell
infection (Spira etal., 1996; Fantini et al.,1997). However,
this mode of dendritic cell dissemination does not apply
to the simple unistratified and tightly junctioned epithe-
lium that covers the endocervix, rectum, or the gastroin-
testinal tract (Brandtzaeg et al., 1997).
Following the pioneering morphological studies of
Phillips (reviewed in Phillips, 1994), we reconstituted the
first step of HIV infection in an in vitro model of the
simple epithelial cell line barrier. Addition of peripheral
blood mononuclear cells (PBMC) infected with HIV pri-
mary isolates (HIV1 PBMCs) to the apical pole of epithe-
lial cells induces the massive polarized budding of vi-
ruses. The newly formed virus is rapidly internalized by
the epithelial cell, transcytosed toward the basolateral
pole of the cell, and released, still infectious, into the
serosal environment. From there, infection could spread.
Importantly, HIV transcytosis occurred in a short time
frame, between 30±150 min, and the epithelial cells ap-
parently remained uninfected, as in vivo. Moreover, di-
rect contact between the apical surface of the epithelial
cell and HIV1 PBMCs was required, as internalization
and transcytosis of cell-free viruses was negligible (Phil-
lips, 1994; Bomsel, 1997).
We now have used this experimental system to inves-
tigate the intracellular site where dIgA or IgM (specific
for the anti-HIV envelope protein) encounters HIV. We
wanted to determine if intracellular interactions between
pIgs and HIV neutralized virus spread and to assess the
ability of epitope specific dIgAs and IgMs to block virus
transmission. Experiments were performed with both
human epithelial cell lines and intestinal biopsies.
Figure 1. HIV Transcytosis Is Blocked by Specific Anti-HIV Poly-
meric IgA or IgM Loaded in the Cell via the pIg-R Basolateral-to-
Results and Discussion Apical Transcytosis Pathway
(a) Characterization of the polyclonal dIgA and IgM anti-HIV enve-
Serosal Exposure of the Epithelial Barrier lope protein against the HIV envelope protein precursor gp160. Poly-
meric Igs (IgM): nonspecific (nonspecific dIgA [30 mg], anti-HIV enve-to Anti-HIV dIgA and IgM Antibodies
lope protein dIgA [30 mg], IgM [30 mg], or IgM, 1:10 [3 mg]) or withNeutralizes HIV Transcytosis
additional anti-SC serum (1 anti-SC) were basolaterally loaded inThe local mucosal immune response is of the dIgA or
epithelial cells (25 or 15 min, respectively) before mucosal (apical)IgM subtype. In addition to its best-known effector role
addition of HIV1 cells. Transcytosis was evaluated in the basolateral
in secretions, an additional effector site for mucosal medium 150 min later by p24 antigenemia. Results are presented as
dIgA may be within the epithelial cell (Mazanec et al., percentof transcytosis in absence of Igs (standard). HIVtranscytosis
was induced from NDK-CEM T cell lines (b) or from HIV1 PBMCs (c).1993; Burns et al., 1996). We therefore investigated
whether dIgA or IgM (directed against the HIV envelope
protein) could inhibit HIV transcytosis across a model both of which express pIgR: the endometrial HEC-1 cell
epithelial cell. line and the intestinal HT29 cell line (Ball et al., 1995;
Dimeric IgA and IgM were each purified from pooled Denning, 1996). HIV-infected cells, either CD41 T cell
sera of HIV seropositive patients. These purified Ig frac- lines chronically infected with HIV-1 laboratory isolate
tions recognize a recombinant envelope precursor pro- NDK (NDK-CEM cells) or PBMCs infected with primary
tein of HIV, gp160,with high affinity in an ELISA (Figure HIV isolates from either subtype A or B (HIV1 PBMCs),
1a). To assess whether these antibodies had inhibitory were added to the apical surface of the epithelial mono-
activity on HIV transcytosis, dIgA or IgM (30 mg) were layer in order to induce virion budding and transcytosis.
internalized from the basolateral side of an epithelial After 5 min of apical contact, serosal polymeric Igs were
monolayer for 25 or 15 min, respectively (Tamer et al., removed by replacing the basolateral medium with fresh
1995). This brief pulse period is sufficient to load the medium free of antibody, and the coculture was allowed
epithelial transcytotic pathway with pIgR-dIgA or IgM to proceed at 378C for an additional period of 145 min.
complexes (Apodaca et al., 1994; Mellman, 1996; Odo- Since experiments conducted with the two different cell
line barriers gave similar results, data were compiled.rizzi et al.,1996). We used two human epithelial cell lines,
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Transcytosis of HIV derived from NDK-CEM cells was epithelial cell contact, the coculture was fixed and the
intracellular location of HIV virions (assessed using anti-significantly inhibited, up to 60% by dIgA or 80% by
IgM directed against the HIV envelope protein (Figure bodies against the HIV p24 antigen) and of dIgA or IgM
was determined using double-label indirect immunoflu-1b). Similar experiments were performed using HIV1
PBMCs infected with either of two different primary iso- orescence. Excitation from the two different fluoro-
phores was acquired simultaneously (dIgA or IgM in redlate populations (of the A or B subtype) (Figure 1c).
Results were independent of the subtype used, but, and p24 in green) and colocalization of the markers
quantified by overlaying the two images and determiningstrikingly, inhibition of virion transcytosis by dIgA or IgM
was even greater for HIV-1 derived from primary isolates the number of yellow pixels obtained.
Figure 2a shows the overlap of fluorescence in theas compared with highly infectious viruses derived from
NDK-CEM cells. Inhibition by dIgA or IgM was not due first 15 optical sections (each section was 0.5 mm apart).
Careful analysis of each series showed that almost allonly to a block in HIV budding, since virion production
induced by HIV-infected cell contact with the apical epi- p24 signal colocalized with pIgs, as visualized by the
presence of yellow pixels (up to 90% on a line takenthelial surface was unaffected during the assay, as mea-
sured by p24 antigenemia measured in the apical me- randomly in the upper focal plane [Figures 2a, top left
quadrant, and 2c). Regions of colocalization were con-dium (data not shown).
In control experiments, irrelevant dIgA or IgM or anti- fined to the upper sections corresponding to the most
apical region of the epithelial cell (at the level of the tightHIV envelope protein IgG 2F5 (Muster et al., 1993) did
not modify HIV transcytosis (Figures 1b and 1c; see junctions), whereas no signal could be detected in the
next 10 sections (16±25) that included the basolateralFigures 3 and 4). More importantly, the dIgA or IgM
binding pIgR and their subsequent transepithelial trans- pole of the cell (data not shown). The extent of coloca-
lization strongly suggested that the antibodies trappedport via the pIgR were inhibited by an anti-SC serum
added to the serosal medium. In such a case, HIV trans- the transcytosing virions (as an immune complex) in
an intracellular compartment, most likely the ARE, ascytosis was fully restored (Figures 1b and 1c). This indi-
cates that the inhibitory activity of anti-HIV envelope indicated by its localization. Similar results were ob-
tained using NDK-CEM and dIgA or HIV1 PBMCs colo-protein pIgs was mediated by the pIgR and, therefore,
occurred via the basolateral-to-apical pIg±pIgR com- calized with dIgA or IgM (Figure 2b). Colocalization was
best for HIV1 PBMC and dIgA (Figure 2b), as shownplex transcytotic pathway.
If, in contrast, dIgA or IgM (3 mg/ml) were added to quantitatively above (Figures 1b and 1c). Similar results
were obtained using PBMCs infected with primary iso-the apical compartment 5 min before addition of HIV1-
infected cells and kept therein throughout the assay, lates of HIV-1 subtype B.
The ARE compartment corresponding to the highlytranscytosis was almost unaffected (data not shown).
This concentration of antibody is in excess compared tubulated structure already described in the early 80s
(Abrahamson and Rodewald, 1981; Limet et al., 1985)to the amount of pIgs that reach the apical compartment
during the length of a 150 min transcytosis assay de- has recently regained attention. Rab 17 (Zacchi et al.,
1998) and annexin VI (Ortega et al., 1998) are functionalscribed above (Song et al., 1994b; Mostov and Kaetzel,
1998). Since receptor-mediated internalization of dIgA markers of the ARE. In renal and intestinal epithelial
cells, the NHE3 (Na1/H1 exchanger) localizes in the AREor IgM from the apical surface of the epithelium is negli-
gible (a result of efficient apical cleavage of receptor to and may play a central role in pH regulation and Na1
homeostasis (D'Souza et al., 1998). This may suggestSC), these data indicated that the anti-HIV dIgA or IgM
did not inhibit transcytosis by simply blocking HIV endo- that the luminal environment of the ARE is regulated
and may be slightly different from the extracellular envi-cytosis at the apical pole of epithelial cells but inhibited
virion transcytosis at a later step of the HIV transcytosis ronment. One may suggest the following scheme. First,
HIV endocytosiswould occur through an interaction withpathway.
the apical glycolipid galactosyl ceramide (Bomsel, 1997)
by a low-affinity interaction, and the internalized virus
Neutralization of HIV Transcytosis by Anti-HIV dIgA would be delivered to the ARE. Indeed, this glycolipid
and IgM Antibodies Occurs Intracellularly colocalizes with HIV in an apical compartment (M. B.,
The current view of membrane traffic in polarized epithe- unpublished data). Once in the specific luminal environ-
lial cells is that both apical-to-basal and basal-to-apical ment of the ARE (reduced pH, ionic strength), HIV inter-
transcytosis pathways meet at the level of the apical action with its lipidic carrier would be displaced (Olivotto
recycling endosome (ARE), a tubulated endosomal com- et al., 1996) by the higher affinity binding site of the
partment located apically at the level of tight junctions polymeric anti-HIV Ig en route to the plasma membrane.
in epithelial cell lines (Apodaca et al., 1994; Odorizzi et As a result, a ternary complex of HIV, polymeric Ig, and
al., 1996). ARE thus appears to be an important sorting pIg-R would form as shown here.
site for regulating endocytic traffic, especially trans-
cytosis, and should play an important role in polarity
control. Intracellular Ig±HIV Complexes Are Recycled
Apically in the Mucosal CompartmentTo demonstrate whether basolaterally internalized anti-
HIV dIgA or IgM meets transcytosing virions intracellu- We next addressed the fate of these intracellular poly-
meric Ig±HIV complexes. We examined whether thelarly and to determine the meeting compartment, a mor-
phological analysis was performed using laser-scanning complexes remained trapped in the cell, were routed to
the serosal (basolateral) side of the epithelial barrier, or,confocal microscopy. After 90 min of HIV-infected cell±
Immunity
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the apical (Figure 3, Apical) but not basolateral medium
(Figure 3, Basolateral). As controls, irrelevant dIgA or
IgM were used in similar experiments. Alternatively, the
anti-HIV envelope protein dIgA or IgM was added api-
cally solely during the chase period (Figure 3, Apical) or
apically together with the HIV1 PBMCs and therefore
removed during the washing step preceding the chase
period (data not shown). Ig±HIV complexes were not
precipitated in any of these cases. These results indicate
that virions intracellularly colocalized with anti-HIV dIgA
or IgM in the ARE had complexed with their HIV ligand
and were recycled to the mucosal pole most likely con-
veyed by the pIgR in the last leg of its transcytosis
journey, en route into the apical secretions. The pIg±HIV
immune complex was most likely released at the muco-
sal (apical) pole as a consequence of SC cleavage at
the epithelial apical membrane.
Thus, mucosal pIgs can capture antigenic targets not
Figure 3. HIV Neutralized Intracellularly Is Cleared from the Epithe-
only under the secretory form within mucosal secretionslial Cell Line Barrier Using the Last Leg of the pIg-R Pathway and
but also at an earlier step, namely, during their trans-Released in the Mucosal Environment as a Complex with dIgA or IgM
cytosis across epithelial cells. Furthermore, in regardsHIV transcytosis was assayed as in Figure 1 with antibody-free
to the fate of the pathogen, our results clearly show thatmedium inthe basolateral chamber (lane 1 and 2) or after basolateral
HIV was redirected from an intracellular compartmentexposure to nonspecific polymeric Igs (lane 3) or to an anti-HIV
envelope protein (dIgA, lane 4; IgM, lane 5). After a 2 hr pulse at toward the apical medium as a complex with the pIg.
378C, HIV1 cells were discarded and the epithelium chased for an While we show that intracellular neutralization does in-
additional hour in cell-free medium (lanes 1, 3, 4, and 5) or with deed occur in vitro, its occurrence in vivo depends addi-
polymeric IgA and M (lane 2). At the end of the chase period, both tionally on cellular expression of the pIg-R and localiza-
apical (Apical) and basolateral (Basolateral) media were collected
tion of IgM or dIgA secreting blasts in the mucosa. Theand subjected to immunoprecipitation with anti-a or -m chain anti-
pIg-R is expressed in a decreasing gradient along thebodies and anti-SC serum. The precipitate was resolved by SDS-
crypt-villus axis of the mucosa but is present near thePAGE, electrotransfered, and blotted for HIV p24. As a control, an
immune complex between HIV and polymeric Igs was formed and tip of the villus, at least in humans (Brandtzaeg et al.,
directly precipitated as the apical media (lane 6). 1997; Brown et al., 1976). Furthermore, pIg-R expression
is highly increased by thecytokine environment,namely,
by INFg, a cytokine rapidly expressed during inflamma-
more likely, were directed to the mucosal (apical) pole tion (Brandtzaeg et al., 1997). In the human mucosa,
following the last step of the constitutive transcytotic dIgA- and IgM-secreting blasts exhibit the same de-
pathway of the pIg/pIg±R complex. Antibody±HIV com- creasing gradient like localization, as mentioned above,
plexes were allowed to form as described above. After along thecrypt-villus axis (Brown et al., 1976). The possi-
90 min, HIV1 PBMC were removed from theapical cham- bility of intracellular neutralization in humans is, there-
ber and the apical surface extensively washed to free fore, highly likely.
it of infected cells. The epithelial cell line barrier was Since the polymeric Igs A and M used in our studies
recultured with fresh apical and basolateral media for were purified from a group of patients infected with
an additional hour at 378C. HIV-1 subtype D, and since the primary isolates used
After this chase period, the epithelial barrier was fixed to infect the PBMCs were from other subtypes (A or
and the apical and basolateral media were collected. At B), the neutralizing epitopes are likely to be conserved
the morphological level, no pIgs or p24 signal could be continuous or conformational epitopes on the HIV enve-
detected in the epithelial cell line monolayer by double lope protein. We next investigated which epitope(s) on
immunofluorescence and confocal microscopy analysis the HIV envelope protein was the determinant for intra-
(Figure 2a, 1 chase), indicating that both had exited the cellular HIV neutralization.
cell. To determine if the virus, pIg, and pIgR remained
associated as a complex and to determine the extracel- The ELDKWA Epitope Is One of the Motifs
lular compartment to which they were delivered, apical that IgM or Dimeric IgA Recognize
and basolateral media were analyzed for pIg±HIV com- to Neutralize HIV Transcytosis
plex content by immunoprecipitation of the pIgs and The dIgA and IgM shown to inhibit HIV transcytosis
Western blot of the precipitate for HIV-p24 antigen. As (Figures 1band 1c) were polyclonal. Despite a significant
specific activity for HIV envelope gp160 in ELISA (Figureshown in Figure 3, pIg-HIV could only be detected in
(b) Similar samples as described above for the pulse condition were generated with the following modifications. Either dIgA or IgM were
basolaterally loaded (BL: dIgA, IgM), and the apically added HIV-infected cells were either NDK-CEM cells or HIV1 PBMCs. For each sample,
overlap of three focal planes above (I) and below (II) the junctional complex and around the upper level of the nucleus (III) are shown. Scale
bar 5 5 mm.
(c) For samples of (b), overlapping was analyzed along a line drawn on section I, as described in (a), and shows an extensive overlap for HIV
by polymeric Igs.
Immunity
282
Figure 4. Inhibition of HIV Transcytosis by Various Monoclonal IgM
Anti-HIV Envelope across a Human Epithelial Cell Line Barrier
In a similar assay as described in Figure 1, the serosal pole of
the epithelial cell line barrier was exposed to one of the various
monoclonal IgM anti-HIV envelope proteins at the indicated concen-
tration. HIV transcytosis was induced from HIV1 PBMCs. Trans-
cytosis was evaluated in the basolateral medium 150 min later by
p24 antigenemia. Results are presented as percent of transcytosis
in the absence of Igs (standard). Values are means 6 SEM of at
least three independent experiments.
1a), the viral epitopes involved in neutralization were
undefined. To identify these viral determinants, four anti-
HIV envelope protein monoclonal IgMs produced from
immortalized B cells were assayed for their capacity
to neutralize HIV transcytosis. These IgMs recognize
defined epitopes distributed along the entire length of
the HIV envelope protein subunits and are suspected Figure 5. The Conserved Sequence ELDKWA Is One Epitope In-
volved in the Intracellular Neutralization of HIV by Polymeric Igsto have a biological significance in HIV pathogenesis.
One of these IgMs, the CA45C, exhibited a surprisingly (a) Reversion on monoclonal IgM and polyclonal D-IgA and IgM
across a human epithelial cell line barrier. In a similar assay, de-high capacity for inhibiting HIV transcytosis (up to 90%
scribed in Figure 1, the serosal pole of the epithelial cell line barrierwith 500 ng) initiated from epithelial apical contact with
was exposed to one of the various monoclonal IgM anti-HIV enve-either HIV1 PBMCs (Figure 4) or NDK-CEM or IIIb-CEM
lope prteins that had been previously preincubated (1) or not (2)
cells (data not shown). Again, transcytosis of virus from with the ELDKWA peptide. HIV transcytosis was induced from HIV1
HIV1 PBMC was always inhibited more efficiently than PBMCs. Transcytosis was evaluated in the basolateral medium 150
that observed with HIV-infected NDK- or IIIb-CEM cells. min later by p24 antigenemia. Results are presented as percent of
transcytosis in absence of Igs (standard). Values are means 6 SEMCA45C is an IgM produced from an EBV-immortalized
of at least three independent experiments.B cell immunized in vitro with a peptide located in a
(b) Specific activity of the polymeric Igs for the ELDKWA peptideconserved region of the extracellular domain of gp41.
(aa 662±667), the aa 642±665 peptide recognized by the CA45C IgM,
We have previously shown that expression of antibodies and the aa 630±59 peptide in ELISA. The dotted line represents the
to this epitope correlates with protection in children background level.
(Fraisier et al., 1995). Interestingly, the last five amino
acids of the C-terminal region of this CA45C peptide
overlap with the ELDKWA epitope (Purtscher et al.,
1996). This epitope is recognized by IgG 2F5, the only this reversal correlated with recognition in ELISA of the
ELDKWA peptide by the sole CA45C IgM, albeit with adescribed Ig of the G isotype against the gp41 HIV enve-
lope protein subunit able to neutralize infection by all lower efficiency than the 2F5 IgG. In contrast, a juxta-
posed peptide covering amino acids (aa) 630±659, whichprimary isolates. This striking homology prompted us
to test whether the ELDKWA hexapeptide (669±674) was has also been shown to inhibit infection by HIV of sev-
eral target cell types (Jiang and Lin, 1995), was neitheran epitope involved in the neutralization of HIV trans-
cytosis. The various monoclonal IgMs were preincu- recognized by the CA45C IgM (Figure 5b) nor reversed
its neutralization capacity when preincubated with thebated with the ELDKWA peptide in an attempt to block
the corresponding recognition site on the IgM molecule CA45C IgM (Figure 5a).
Finally, we investigated whether the ELDKWA epitopeand subsequently applied at the serosal pole of the
monolayer, as described above, to test their capacity was also involved in the inhibition of HIV transcytosis
mediated by the IgM or dIgA purified from seropositivefor interfering with HIV transcytosis. As shown in Figure
5a, the CA45C IgM was the only IgM antibody whose patients. Dimeric IgA or IgM were preincubated with the
ELDKWA peptide and assayed against HIV transcytosisability to block HIV transcytosis initiated from HIV1
PBMCs of subtype A or B was reversed as a result of initiated from HIV1 PBMCs of subtype A or B. As shown
in Figure 5a, for both dIgA or IgM a significant part of thepreincubation with the ELDKWA. Figure 5b shows that
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inhibition induced by these Igs was reversed, whereas cell transmigration during the assay was ascertained
by a set of fluorescent assays, as already describedpreincubation with other peptides was ineffective. The
recognition by both IgM and dIgA of the ELDKWA in (Bomsel, 1997). Altogether, these data demonstrated
that during the transcytosis assay HIV-infected cells re-ELISA (Figure 5b) confirms the specificity of this rever-
sal. Additionally, the aa 630-659 peptide did not reverse mained on the apical side of the biopsy, as we have
already shown for epithelial cell line barriers.the inhibition induced by the pIgs (data not shown) nor
was it recognized by the antibody in ELISA (Figure 5b). After the 120 min period, the mucosal and serosal
medium were collected. The apical medium was centri-Taken together, these results suggest that the ELDKWA
sequence is one of the epitopes that IgM or dimeric IgA fuged to eliminate the HIV1 cells and filtered. The HIV
content of the media was evaluated by p24 antigenemiarecognizes in neutralizing the mucosal entry of HIV by
mucosal to serosal transcytosis. Since the ELDKWA after amplification by coculture with uninfected CD41
cells for 7±14 days. As shown in Figure 6d, infectiouspeptide did not completely reverse the pIg inhibition
induced by dIgA or IgM, either the peptide was not HIV could be amplified from the serosal medium using
either NDK-CEM cells or HIV1 PBMCs, most likely fol-efficient at neutralizing all of the antibody or, more likely,
the neutralization involved additional epitopes acting in lowing transcytosis across the epithelial surface of the
biopsy and further diffusion. In contrast, Figure 6da cooperative manner.
One can suggest that, in its native conformation, the shows that when cell-free virions from primary isolates
were added in the mucosal chamber, no signal couldELDKWA epitope is highly accessible to pIgs, as has
been shown for the reciprocal IgG 2F5 (Muster et al., be detected in the serosal medium collected 120 min
later. Furthermore, when the biopsy accidentally failed1993). The high-affinity binding of pIgs may keep the
virus tightly associated to be able to redirect it into the to maintain its tissue electrical resistance, a sign of func-
tional rupture of the barrier, infected cells could be de-mucosal environment. It is worth noting that there was
no direct linear correlation between their capacity to tected in the serosal chamber (data not shown).
In vivo, epithelial apical surfaces are covered with aneutralize viral fusion (Ebersold et al., 1992; Fraisier et
al., 1994) and HIV transcytosis (this study). This is not coat of thick filamentous brush border glycocalyx made
of highly glycosylated proteins, some of which are inte-surprising, since HIV transcytosis does not require virus
fusion with the epithelial target. gral membrane enzymes. This apical coat, up to 500 nm
in thickness, may facilitate digestion of local nutrients,Whereas the aa 642±665 peptide is immunodominant
in the IgG response of HIV seropositive patients, ELDKWA but it may also protect against various luminal patho-
gens. An important issue for HIV mucosal transmissionis not (Calarota et al.,1996). However, preliminary results
(H. H. and M. B., unpublished data) indicate that anti- as a result of contact between HIV infected cells and
mucosal surface is whether, in vivo, this highly glycosy-HIV envelope protein S-IgA from the colostrum of HIV-
seropositive patients strongly reacts with this peptide. lated and charged structure could impede such cell±cell
interaction and therefore HIV budding, which is a prereq-Furthermore, these S-IgAs always neutralized HIV trans-
cytosis 10- to 100-fold more efficiently than the paired uisite for thesubsequent transcytosis. Our results show-
ing HIV transcytosis across a duodenal biopsy stronglyIgG (Hocini et al., 1997). This suggests that different
functional epitopes can induce specific isotypic humoral suggest that this is not the case. One may hypothesize
that this interaction occurs in a multistep process. First,responses with highly variable efficiency depending on
the humoral compartment. HIV1 PBMCs would interact with the highly negatively
charged glycocalyx by induction of clusters of positively
charged surface proteins (Olivotto et al., 1996). This in-HIV Transcytosis Initiated from HIV1 PBMCs
Occurs through a Human Intestinal Biopsy teraction may stabilize the infected cells and, in turn,
may favor their polarization (Phillips, 1994) and subse-To approach the in vivo situation as closely as possible,
we next investigated whether a human intestinal endo- quently provide direct access to the epithelial apical
membrane components, now accessible beneath thescopical biopsy could support HIV transcytosis. Duo-
denal biopsies were mounted in Ussing chambers (Hey- glycocalyx mesh. The occurrence of such an active
mechanism may not apply to cell-free HIV inept at reor-man et al., 1988; Saidi et al., 1995). This device allows,
in addition to temperature control and tissue oxygena- ganizing its membrane but too large to diffuse freely
across the glycocalyx mesh, as carefully analyzed withtion, the preservation of the biopsy as a functional bar-
rier. Media contained in two independent chambers size-defined probes in the rabbit intestine by Frey et al.
(1996). Alternatively, HIV1 cells may even be inducedbathe the mucosal (apical) and serosal (basolateral)
faces of the tissue, respectively, and the biopsy itself to digest the glycocalyx via secretion of appropriate
enzymes, as occurs for other pathogens. In any event,constitutes the interface. HIV1 cells or cell-free virus
a striking difference exists between cell-free HIV andwere added to the mucosal chamber, and the cell±cell
newly budded HIV resulting from intercellular interac-interactions were allowed to occur for 120 min at 378C.
tions.The viability of the tissue, i.e., electrogenic activity and
barrier capacity, was first monitored using established
parameters. Potential difference and short-circuit cur- IgM against ELDKWA Epitope Blocks HIV
Transcytosis across a Humanrent (Figure 6a) remained constant (1 mV and 40 mA/
cm2), respectively. [14C]mannitol fluxes and the electrical Intestinal Biopsy
The neutralization capacity of the CA45C IgM againstresistance (R) (Figures 6b and 6c) remained stable. In
contrast, addition of EDTA to the medium, which is HIV transcytosis was monitored using two human duo-
denal biopsies, as described above. The CA45C IgMknown to dissociate the junctional complexes, induced
a sharp decrease in R. Furthermore, the absence of HIV1 was pulsed for 30 min in the serosal compartment, then
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Figure 6. HIV Transcytosis Occurs through a
Human Duodenal Biopsy
The transcytosis assay was performed across
human duodenal biopsies mounted as a tight
functional barrier in Ussing chambers.
(a) The viability of the biopsies was monitored
by the constant recording of potential differ-
ence (PD) and short-circuit current (Isc),
which remained stable throughout the time
course of the experiments (n 5 7 biopsies).
(b and c) The integrity of the biopsies was
controlled by the electrical resistance (R) and
[14C]mannitol fluxes, which were maintained
at the initial steady-state value.
(d) Transcytosis was initiated by addition of
HIV1 PBMCs in the mucosal compartment.
Alternatively, cell-free HIV was used as the
infectious agent. After 130 min, the serosal
medium was collected and tested for its HIV
infectivity. In some experiments, CA45C IgM
was pulsed from the serosal side of the
biopsy for 30 min before mucosal addition of
HIV1 PBMCs. The serosal medium was ana-
lyzed for its HIV content after up to 2 weeks
of coculture with uninfected PBMCs and
quantitated by p24 antigenemia. Values are
means 6 SEM of at least six independent
experiments.
HIV1 PBMCs were added in the mucosal compartment. anti-HIV IgM response may be protective against HIV
(Van de Perre et al., 1994), even if this IgM inductionAfter 15 min, a time period probably too short to allow
significant transcytosis (Heyman et al.,1988), the serosal would probably involve a cooperation with T cells as
well as with elements of innate immunity (Ahmed andmedium was replaced by fresh medium free of IgM.
Following a 150 min incubation, the serosal medium was Gray, 1996; Brandtzaeg, 1997).
The presence of anti-HIV S-IgA at mucosal sites hasanalyzed for its HIV content, but no signal could be
detected (Figure 6d). This indicates that the CA45C IgM been correlated with protection of HIV-exposed but un-
infected individuals in sero-different couples, despitehad also neutralized or at least impaired HIV transcytosis
across the duodenal biopsies. Neutralization of HIV many years of exposure to the HIV-infected partner
(Mazzoli et al., 1997). Strikingly, these S-IgAs recognizetranscytosis by pIgs against HIV envelope protein there-
fore appears not to be restricted to epithelial cell lines HIV envelope protein epitopes located essentially on
the gp41 transmembrane subunit but not on the gp120but also applies to human mucosa as well.
Since our results indicated that IgM can induce intra- surface subunit or the gp160 precursor. In contrast,
mainly gp120 and gp160 epitopes were recognized bycellular neutralization in a cell line as well as in a human
duodenal epithelial barrier, one may wonder whether the S-IgA of the HIV1 partners. These results are in good
agreement with the possible immunodominance of thethis pathway could be used in vivo. Specific IgMs are
known to be secreted essentially during the primary conserved ELDKWA peptide in the mucosal humoral
response in contrast to its lack in the systemic one (seeinfection as first local immune response, whereas the
secondary response is thought to be of the dIgA type above). Taken together, these data emphasize the role
of the gp41 HIV envelope protein subunit in the mucosal(Brandtzaeg, 1997). However, specific anti-HIV S-IgM
has been detected in cervico vaginal secretions or protective response directed at both continuous and
conformational epitopes. Our data on the role of thesperm from HIV seropositive patients. Furthermore, the
presence of anti-HIV S-IgM as well as IgM-producing B ELDKWA peptide of gp41 in the pIg-mediated neutral-
ization and the above observations in sero-different cou-cells in human milk has been correlated with an absence
of transmission to the offspring during lactation (Van de ples suggest that S-IgA detected in exposed uninfected
individuals may be capable, among other roles, of neu-Perre et al., 1994). Even more puzzling, the continuous
production of the anti-HIV envelope protein S-IgM has tralizing HIV transmission in the mucosal lumen or intra-
cellularly in the epithelium.been demonstrated in 14 of 16 long-term survivor chil-
dren infected by vertical transmission (Fraisier et al.,
1995). Taken together, these results support the protec- Conclusion
We have shown in this study that dIgA and IgM directedtive role of IgM at various stages of the infection. A
vaccine strategy that could also induce a prolonged against theHIV envelope protein can neutralize HIV entry
dIgA and IgM in HIV-1 Mucosal Infection
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cells and epithelial cells, the basolateral Igs were removed by ex-via transcytosis in epithelial cells by intracellular capture
changing the basolateral medium for fresh antibody-free medium.of the virus and clearance into the mucosal environment.
Transcytosis was allowed to proceed by reculture of the system atA conserved epitope of the viral envelope involved in this
378C for 145 min and was assessed as indicated above. In experi-
mechanism has been characterized. Such a protective ments involving a chase period (morphology, Figure 2; immunopre-
epitope may be useful when considering future vaccine cipitation, Figure 3), transcytosis was allowed to occur for 145 min.
In the chase experiments, HIV-infected cells were removed at thestrategies.
end of the HIV1 and epithelial cell coculture, and the epithelial apical
surface was extensively washed with RPMI and 10% FCS, includingExperimental Procedures
one wash with trypsin-EDTA for 45 s at 378C. The entire washing
procedure was controlled as follows. HIV-infected cells were pre-Viruses
loaded with calcein-AM (Bomsel, 1997) prior to application to thePrimary isolates were obtained by culture of PBMCs from HIV-1
epithelia in the apical chamber and the experiment was performed.infected Cameroonese women (subtype A, nonsyncytia-inducing
At the end of the washing procedure, we verified by visual inspection[NSI] phenotype) and from HIV-1 infected Italian mothers (subtype
under the fluorescence microscope that all of the infected cells hadB, syncytia-inducing [SI] and NSI phenotypes) (Scarlatti et al., 1991).
been removed, thereby confirming the efficacy of the washes. TheThe viral cell±free supernatants were used for PBMC infection.
HIV1 cell-free epithelial monolayer was then recultured for an addi-
tional 1 hr period with fresh apical and basolateral media at 378C.Cells
At theend of this period,apical and basolateral mediawere collectedPBMCs were obtained from the pooled blood of healthy donors as
and the epithelial monolayer was fixed with 4% paraformaldehyde,described (Scarlatti et al., 1991). HIV 1 PBMCs were PBMCs in-
as already described (Bomsel, 1997). Alternatively, antibodies werefected with one of the viruses mentioned above, as in Scarlatti et
added apically 5 min prior to addition of HIV-infected cells at aal. (1991), and were used at day 10 postinfection for neutralization
concentration 1/100 of that added basolaterally.of HIV transcytosis across epithelial cell lines or biopsies. NDK or
IIIb-CEM were CD41 T cell lines chronically infectedwith HIV labora-
tory isolates NDK or IIIb as described in our previous study (Bomsel, Immunoprecipitation
1997). Epithelial cells used were the human HEC-1 endometrial cell Apical and basolateral media (each from three combined epithelial
line (Ball et al., 1995) or intestinal cell line HT-29 (ATCC) (Denning, monolayer samples) collected after the chase period, as described
1996) expressing the pIgR, grown on a permeable support as pre- above, were processed for immunoprecipitation with anti-human
viously described (Bomsel, 1997). We verified that the cells ex- IgA or IgM antibody (Immunotech) and protein A/G Sepharose
pressed pIgR basolaterally by indirect immunofluorescence using (Pierce) (Song et al., 1994a) in the absence of detergents. Anti-
an anti-SC sera (1/500) as primary antibody (data not shown). human IgA or IgM antibodies (1/100) and anti-SC serum (1/250) were
used for precipitation. The samples were analyzed by 12% SDS-
Antibodies PAGE and Western blot for p24 with a monoclonal anti-p24 antibody
Human Dimeric dIgA and Pentameric IgM V7.8 (100 ng/ml as recommended by the AIDS Research and Refer-
Dimeric dIgA (dIgA) and pentameric IgM (IgM) were isolated from ence Reagent Program, NIAID). Detection was achieved using the
100 ml of 50 pooled sera obtained from HIV-positive patients at Vector-ELITE amplification kit (Biosys, CA) and chemoluminescence
Bangui, Central African Republic, and purified by serial chromatog- (ECL, Amersham). Films were never exposed longer than 1 hr. Exper-
raphy. Dimeric IgA and IgM were quantified by a symmetrical sand- iments were performed three times. As positive control, polymeric
wich ELISA, and the binding activity of dIgA and IgM Abs to HIV Ig±virion complexes were first allowed to form by direct incubation
envelope protein was detected by ELISA using recombinant gp160 of cell-freevirion with pIgs (30 mg/ml), then precipitated as described
(MN/LAI VV. TG.9150, Pasteur Merieux, France) (Belec et al., 1995). above.
Human Monoclonal IgMs
F432 is a monoclonal IgM obtained from the spleen lymphocytes
Transcytosis across the Human Intestinal Biopsiesof an asymptomatic HIV-seropositive patient restimulated in vitro
Human duodenal mucosal fragments were obtained as part of biop-with the aa 583±599 peptide of the HIV envelope protein gp41 sub-
sies performed for routine clinical purpose from healthy donors,unit (Ebersold et al., 1992). CF41 and CA45C are monoclonal IgMs
after informed consent and in agreement with a protocol acceptedobtained by in vitro immunization of PBMCs from an HIV-seronega-
by the local clinical research department and ethics committee.tive individual with the following peptides: aa IHIGPGRAFY of the
All the specimens used were confirmed as presenting a normalV3 loop of the HIV envelope protein gp120 subunit (HIV-1, MN) for
histological aspect. They were mounted within 1 hr of sampling inCF41 and aa 642-ISHLIEESQNQQEKNEQELLELDK-665 of the HIV
an Ussing chamber as a tight and functional barrier as describedenvelope protein gp41 subunit (HIV-1, BH10) for CA45C (Fraisier et
(Heyman etal., 1988; Saidi et al., 1995). HIV transcytosis was inducedal., 1994). DR3 and C31 are monoclonal IgM and IgG, respectively,
by addition of HIV1 PBMCs (subtype A or B, 2 million cells) to theobtained from immortalized PBMCs of an HIV-seropositive patient;
mucosal reservoir and incubation for 120 min. At the end of thethe PBMCs were immortalized without previous in vitro immuni-
experiments, the entire contents of the mucosal and serosal com-zation.
partments were collected and analyzed for their HIV infectivity byHuman IgG
coculture with uninfected PBMCs. Their HIV content was measured2F5 is a monoclonal IgG (Muster et al., 1993).
by p24 antigenemia, as above, at regular intervals up to 14 days.
In the neutralization experiment, CA45C IgM (1 mg/ml) was pulsed
Transcytosis Assay across an Epithelial Cell Line Barrier
from the serosal medium for 30 min before addition of HIV1 PBMCs
Standard Assay in the mucosal reservoir, and the serosal medium was exchanged
Virion transcytosis induced by contact of HIV-infected cells with an for fresh medium free of IgM 15 min later. The assay was performed
epithelial cell line barrier was performed as previously described as above.
(Bomsel, 1997). Results are expressed either as picograms per milli-
liter of HIV-p24 oras percentof transcytosis observed inthe absence
of antibody, referred to below as standard. Immunofluorescence
Fixed cells were processed for intracellular staining (Bomsel, 1997;Antibody Inhibition
dIgA or IgM was added basolaterally in 120 ml for 25 or 15 min, Turpin et al., 1998). The following antibodies were used: anti-p24
MAb V7.8 (V100 ng/ml, as recommended by the AIDS Research andrespectively, to saturate the transcytosis pathway prior to addition
of the HIV-infected cells in the apical chamber. This preincubation Reference Reagent Program, NIAID), followed by biotinylated sheep
anti-human IgG antibodies (1/300, Vector Biosys, CA) and streptavi-time was optimized to maximize inhibition (data not shown). This
brief pulse at high-antibody concentration was chosen because din-Texas red (1/500, Pierce) FITC-goat anti-human IgA or FITC-
goat anti-human IgM (1/150, Jackson) and FITC-sheep anti-goat Igwe have previously shown that the dIgA intracellular transcytosis
pathway could differ according to the antibody concentration (Mos- (1/150, Jackson). Coverslips were mounted in Mowiol and observed
by confocal microscopy (Bio-Rad 1024 with a 603 optique [Nikon])tov and Kaetzel, 1998). After 5 min of contact between HIV-infected
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as described (Bomsel, 1997; Turpin et al., 1998). Consecutive sec- D'Souza, S., Garcia-Cabado, A., Yu, F., Teter, K.,Lukas, G., Skorecki,
K., Moore, H.P., Orlowski, J., and Grinstein, S. (1998). The epithelialtions were 0.5 mm apart. Images were processed using the double-
labeling Laser Sharp software. Colocalization appeared as yellow sodium-hydrogen antiporter NA1/H1 exchanger 3 accumulates and
is functional in recycling endosomes. J. Biol. Chem. 273, 2035±2043.pixels after merging two sections recorded at the same xz level in
each channel. Further analyses of the colocalization were performed Denning, G.M. (1996). IL-4 and IFN-gamma synergistically increase
by comparing red to green pixel distribution ona line taken randomly total polymeric IgA receptor levels in human intestinal epithelial
across a section; the intensity histograms obtained for each channel cells. Role of protein tyrosine kinases. J. Immunol. 156, 4807±4814.
along the chosen line were then compared point by point and pre- Ebersold, A., Boyer, V., Klasse, P.J., Holnigue, M., Fraisier, C., Coc-
sented as a fluorogram (or histogram) using the Elite software chi, J.M., Pipkorn, R., Blomberg, J., and Desgranges, C. (1992).
(Coulter, France). Human and murine monoclonal antibodies directed against a con-
served sequence from gp41 (aa583±599) of human immunodefi-
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